… Recently, improved vaccine development using dendritic cells … a whole tumor lysate-pulsed
DC vaccine to 51 patients with … -1 in advanced epithelial ovarian cancer and melanoma [57]. …

… study is to evaluate the safety, feasibility, and efficacy of the addition of dendritic cell vaccines
… The proliferation of T cells after stimulation with tumor lysate-pulsed DC was evaluated by …

… Dendritic cells (DC) are used to develop cellular cancer vaccines due to their role as … resulted
in prolonged disease-free survival in patients with resected melanoma, with a disease-free …

… We also showed that the addition of dendritic cells to CIK therapy, common for CRC
treatment, did not provide any clinical benefit over CIK therapy alone and that CIK therapy is …

… types of tumor antigens and vaccine technologies (dendritic cells, … vaccination have been
demonstrated in adult melanoma … phase II trial investigating an autologous tumor lysate-pulsed …

… Microsatellite instability in patients with colorectal cancer is … who received a tumor
lysate-pulsed DCs vaccination in … of thirteen people with metastatic melanoma, vaccination with …

… approximately one third of melanoma patients treated with TILs, … with dendritic cells in patients
with colorectal cancer. In a … an autologous tumor lysate-pulsed dendritic cell vaccine and …

… as well as cancer vaccines, can capably compromise tumor … mg/kg) in patients with advanced
melanoma could result in … (ORR) in a phase 3 trial in patients with advanced melanoma (…

… , vaccinating hundreds of GBM patients and confirming feasibility and safety. Many of these
studies … of recent vaccination trials, relevant parameters of the vaccines themselves and of …

… the efficacy of autologous tumor lysate pulsed DCs (TLDCs), … sarcoma, melanoma, ovarian
and lung cancers [32]. Our current … dendritic cell vaccine showed a substantial decrease in the …